Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Norovirus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT07254728
What this trial is testing

Evaluate Vaxart's Oral Bivalent GI.1/GII.4 Norovirus Vaccine in Healthy Lactating Females and Their Nursing Infants

Who this might be right for
Norovirus Infections
Vaxart 76
Early research (Phase 1)Study completedNCT03125473
What this trial is testing

Dose-Optimization Trial of VXA-G1.1-NN in Healthy Volunteers

Who this might be right for
Norovirus Gastroenteritis
Vaxart 66
Early research (Phase 1)Study completedNCT01168401
What this trial is testing

Bivalent Norovirus Vaccine Study

Who this might be right for
Gastroenteritis
Takeda 102
Not applicableStudy completedNCT00674336
What this trial is testing

Infectivity of Norovirus in Shellfish Treated With High Hydrostatic Pressure Processing-Human Challenge Study

Who this might be right for
Healthy
Emory University 51
Testing effectiveness (Phase 2)Study completedNCT02153112
What this trial is testing

Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle (VLP) Vaccine in Children

Who this might be right for
Norovirus
Takeda 840
Early research (Phase 1)Study completedNCT05213728
What this trial is testing

A Phase 1, Open-label, Safety and Immunogenicity Study of an Oral Multi-dose Administration Regimen With an Adenoviral-vector Based Tablet Norovirus Vaccine (VXA-G1.1-NN) Administered to Healthy Adult Volunteers

Who this might be right for
Norovirus Infections
Vaxart 8
Early research (Phase 1)Looking for participantsNCT04691622
What this trial is testing

Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts

Who this might be right for
Viral InfectionHematopoietic Stem Cell Transplantation (HSCT)Primary Immunodeficiency Disorders (PID)
Children's National Research Institute 48
Early research (Phase 1)Study completedNCT01435811
What this trial is testing

Dose Range Evaluation of Norovirus Challenge Pool (GII.4, CIN-1)

Who this might be right for
Norovirus Infections
Children's Hospital Medical Center, Cincinnati 60
Not applicableUnknownNCT03342547
What this trial is testing

Identification of Host Factors of Norovirus Infections in Mini-Gut Model

Who this might be right for
Gastrointestinal Infection
Chinese University of Hong Kong 20
Large-scale testing (Phase 3)Study completedNCT05916326
What this trial is testing

Phase III Clinical Trial to Evaluate the Human Norovirus Bivalent (GⅠ.1/GⅡ.4)Vaccine，Recombinant (Hansenula Polymorpha)

Who this might be right for
Norovirus InfectionsNorwalk Gastroenteritis
National Vaccine and Serum Institute, China 8,000
Early research (Phase 1)Study completedNCT04174560
What this trial is testing

Phase I Norovirus Challenge Model

Who this might be right for
Gastroenteritis Norovirus
National Institute of Allergy and Infectious Diseases (NIAID) 48
Testing effectiveness (Phase 2)Study completedNCT02038907
What this trial is testing

Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent VLP Vaccine

Who this might be right for
Healthy VolunteersNorovirus, Prevention
Takeda 420
Early research (Phase 1)WithdrawnNCT02337842
What this trial is testing

Phase I Study to Determine the Optimal Human Challenge Dose for a Norovirus GII.4 Challenge Stock (CIN-1)

Who this might be right for
Gastroenteritis Norovirus
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Study completedNCT04563533
What this trial is testing

Clinical Trial of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris)

Who this might be right for
Acute Gastroenteritis
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 580
Large-scale testing (Phase 3)Active Not RecruitingNCT06524947
What this trial is testing

Clinical Trial of Protective Efficacy of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris)

Who this might be right for
Acute Gastroenteropathy Due to Norovirus
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 6,600
Early research (Phase 1)Study completedNCT06007781
What this trial is testing

Safety and Immunogenicity of HIL-214 in Healthy Japanese Infants

Who this might be right for
Gastroenteritis
HilleVax 21
Not applicableEnded earlyNCT02371538
What this trial is testing

Human Breastmilk in Young Children With Norovirus Infection of the Gut

Who this might be right for
Norovirus Infections
Children's Hospital Medical Center, Cincinnati 4
Testing effectiveness (Phase 2)Study completedNCT05972733
What this trial is testing

Serologic Assay Validation and Proficiency Testing of HIL-214 in Adults

Who this might be right for
Gastroenteritis
HilleVax 80
Not applicableStudy completedNCT06211621
What this trial is testing

Admission Pattern Among Children With Gastro-intestinal Infections Before and During the Covid-19 Pandemic

Who this might be right for
GastroenteritisRota Virus GastroenteritisDehydration in Children+3 more
Region Zealand 600
Early research (Phase 1)Study completedNCT01322503
What this trial is testing

Susceptibility of Human Volunteers With Different Histo-Blood With Different Histo-Blood Group Antigens to Norovirus

Who this might be right for
Healthy Adults
Children's Hospital Medical Center, Cincinnati 40
Next Page